The biggest stories of the day delivered to your inbox.

In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal ... leading to a seven-year ...

Martin Shkreli argued that members of the Wu-Tang Clan should participate in a court battle he’s facing over a rare album they produced as they still hold rights to it. Martin “Pharma Bro ...

Jury selection kicked off Monday in New York for the next chapter of a federal securities trial that could open up the cell adjoining convicted fraudster Martin Shkreli ... including wire fraud.

Why do they call Martin shkreli Pharma Bro? Mr. Shrkeli played a major role ... A total of three of eight charges against Shkreli led to his conviction in August 2017. He faced a sentence of up to 20 ...

Shkreli (R) has frequently clashed with critics on social media A judge has ordered the jailing of ex-pharmaceutical chief executive Martin "Pharma Bro" Shkreli while he awaits sentencing for ...

Given that Martin Shkreli has a lifetime restraining order ... on the launch mentioning Shkreli as a co-founder in the first sentence. It does include a disclaimer, however, which claims that ...

A New York federal judge ordered Martin Shkreli to surrender any copies of ... early Wednesday after serving part of a seven-year sentence for fraud, the federal Bureau of Prisons confirmed.

Pharma CEO Martin Shkreli was arrested on the morning of December 17th on charges of security fraud. He first gained notoriety back in September, after raising the price of a life-saving AIDS drug ...

You remember a guy named Martin Shkreli? If his name rings a bell, it’s probably because back in 2015, he jacked up the price of an old drug — from around $13 a pill to $750. The media dubbed ...

Martin Shkreli, once dubbed ‘Pharma Bro’ for ... Shkreli was released from prison in 2022 after serving much of a seven-year ...

And that means such stocks should continue to be sold short, according to Martin Shkreli, the investor who was sent to prison for securities fraud and whose defense of sharp drug price hikes by a ...